Pharmaceutical Industry Palestine

Pharmaceutical Industry Palestine

Presented By: Talal Nasereddin Chairman

Bitzeit Pharmaceutical Co. Email: ceo@bpc.ps www.bpc.ps

Presented By: Talal Nasereddin Chairman

Bitzeit Pharmaceutical Co. Email: ceo@bpc.ps www.bpc.ps

Industry Brief

• Six Companies operate in Palestine since early 1970s

• Working Capital USD 160 Million Generic Manufacturing Companies

• Estimated market size is $130 million

Export Market

• 25% of total sales goes to export market(Germany, East Europe, MENA)

• Investment in Algeria

• Investment in Malta

Market share

Israeli

Foreign

Palestinian

Key Competitive factors

• Modern facilities and equipments

• Improved Management and Production Processes

• Continuous industry development through international certification (ISOs and GMP)

Industry Potential Growth Indicators

Industry Potential Growth Indicators

Window for Cooperation

• Diversification of products by introducing new products such as: Oncology, natural products, herbal medicine, food supplements, organ transplantation and specialty products as (Freeze dried products)

• Packaging

• Grow investments in Algeria

investment environment in Palestine

• Tax exemptions

• Free trade agreements with Europe, EFTA, USA, CANADA, Turkey, and the Arab Countries

• Italian government insurance and Funding